SCHEMBL6029003

SCHEMBL6029003

COc1ccc(-c2cc[c]c(N)c2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 4/20 0.50
ABL1 P00519 1/20 0.46
ABCB1 P08183 1/20 0.46
BCR P11274 1/20 0.46
MAPK1 P28482 2/20 0.44
NPC1 O15118 1/20 0.44
TP53 P04637 1/20 0.44
CASP3 P42574 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
MAP4K4 O95819 1/20 0.44
ESR2 Q92731 1/20 0.44
TDP1 Q9NUW8 2/20 0.43
ALDH1A1 P00352 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAOB P27338 2/20 0.42
CA12 O43570 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27588540 0.82 CYP3A4 (0.48) DYRK1AABL1ABCB1BCRSMN1; SMN2
SCHEMBL5805933 0.80 ALDH1A1 (0.43) MAPK1NPC1TP53RAB9ASMN1; SMN2
SCHEMBL11099027 0.79 ABL1 (0.52) DYRK1AABL1ABCB1BCRMAPK1
SCHEMBL27720539 0.79 ABL1 (0.47) DYRK1AABL1ABCB1BCRMAPK1
SCHEMBL28824959 0.79 ABL1 (0.52) DYRK1AABL1ABCB1BCRMAPK1
SCHEMBL28095381 0.79 ABL1 (0.47) DYRK1AABL1ABCB1BCRMAPK1
SCHEMBL27588635 0.78 TDP1 (0.50) NPC1TP53RAB9ASMN1; SMN2TDP1
SCHEMBL2021195 0.78
SCHEMBL6019039 0.78 ABL1 (0.46) DYRK1AABL1ABCB1BCRMAPK1
SCHEMBL8913087 0.75 ABL1 (0.43) DYRK1AABL1ABCB1BCRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7087624-B2 Substituted pyrazole compounds TEIKOJU HORMONE MFG. CO., LTD. (JP) 2006-08-08 US disclosed
CN-1553900-A Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents ��ʱ��ʩ����ҩ��˾ 2004-12-08 CN disclosed